Hantz Financial Services, Inc. Merck & Co., Inc. Transaction History

Hantz Financial Services, Inc.

$5.63 Billion
Q3 2024

A detailed history of Hantz Financial Services, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 143,592 shares of MRK stock, worth $14 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

143,592

Previous 150,323 4.48%

Holding current value

$14 Million

Previous $18.6 Million 12.38%

% of portfolio

0.29%

Previous 0.36%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $748,150 - $868,097	-6,731 Reduced 4.48%	143,592 $16.3 Million
Q2 2024 Jul 30, 2024	BUY	$123.8 - $132.96 $18.6 Million - $20 Million	150,323 New	150,323 $18.6 Million
Q1 2024 Aug 06, 2024	SELL	$113.24 - $131.95 $1.32 Million - $1.54 Million	-11,634 Reduced 6.7%	162,137 $21.4 Million
Q4 2023 Aug 06, 2024	SELL	$100.18 - $109.02 $2.31 Million - $2.52 Million	-23,108 Reduced 11.74%	173,771 $18.9 Million
Q3 2023 Aug 06, 2024	SELL	$102.95 - $114.33 $591,962 - $657,397	-5,750 Reduced 2.84%	196,879 $20.3 Million
Q2 2023 Aug 06, 2024	BUY	$108.61 - $118.38 $65,600 - $71,501	604 Added 0.3%	202,629 $23.4 Million
Q1 2023 Aug 06, 2024	BUY	$102.94 - $114.86 $131,248 - $146,446	1,275 Added 0.64%	202,025 $21.5 Million
Q4 2022 Aug 06, 2024	BUY	$87.44 - $112.11 $850,354 - $1.09 Million	9,725 Added 5.09%	200,750 $22.3 Million
Q3 2022 Aug 06, 2024	BUY	$84.53 - $94.96 $358,660 - $402,915	4,243 Added 2.27%	191,025 $16.5 Million
Q2 2022 Aug 06, 2024	BUY	$83.49 - $94.64 $592,445 - $671,565	7,096 Added 3.95%	186,782 $17 Million
Q1 2022 Aug 06, 2024	BUY	$73.51 - $82.4 $745,464 - $835,618	10,141 Added 5.98%	179,686 $14.7 Million
Q4 2021 Aug 06, 2024	BUY	$72.28 - $90.54 $2.43 Million - $3.05 Million	33,667 Added 24.78%	169,545 $13 Million
Q3 2021 Aug 06, 2024	BUY	$71.68 - $78.83 $762,603 - $838,672	10,639 Added 8.49%	135,878 $10.2 Million
Q2 2021 Aug 06, 2024	BUY	$70.31 - $77.77 $423,688 - $468,642	6,026 Added 5.05%	125,239 $9.74 Million
Q1 2021 Aug 06, 2024	SELL	$68.86 - $81.11 $2.14 Million - $2.52 Million	-31,110 Reduced 20.7%	119,213 $9.19 Million
Q4 2020 Aug 06, 2024	BUY	$71.77 - $79.65 $66,817 - $74,154	931 Added 0.78%	120,201 $9.83 Million
Q3 2020 Aug 06, 2024	SELL	$73.18 - $82.95 $77,863 - $88,258	-1,064 Reduced 0.88%	119,270 $9.89 Million
Q2 2020 Aug 06, 2024	BUY	$70.42 - $80.13 $211,189 - $240,309	2,999 Added 2.56%	120,334 $9.31 Million
Q1 2020 Aug 06, 2024	SELL	$63.36 - $87.82 $2.09 Million - $2.9 Million	-32,988 Reduced 21.94%	117,335 $9.03 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Merck & Co., Inc. Transaction History